about
Heat shock protein 90: role in enterovirus 71 entry and assembly and potential target for therapyHigh Genetic Stability of Dengue Virus Propagated in MRC-5 Cells as Compared to the Virus Propagated in Vero CellsHuman SCARB2-mediated entry and endocytosis of EV71Immunological and biochemical characterization of coxsackie virus A16 viral particlesFormulation and immunological evaluation of a trivalent vaccine comprising emulsified submicron particles and inactivated virions of H5N1/EV71/JEVPilot scale production of highly efficacious and stable enterovirus 71 vaccine candidates.Immunogenicity studies of bivalent inactivated virions of EV71/CVA16 formulated with submicron emulsion systems.Purification and characterization of enterovirus 71 viral particles produced from vero cells grown in a serum-free microcarrier bioreactor system.Long-term immunogenicity studies of formalin-inactivated enterovirus 71 whole-virion vaccine in macaques.Delivery of human EV71 receptors by adeno-associated virus increases EV71 infection-induced local inflammation in adult mice.Human SCARB2 transgenic mice as an infectious animal model for enterovirus 71.Protective efficacy of VP1-specific neutralizing antibody associated with a reduction of viral load and pro-inflammatory cytokines in human SCARB2-transgenic mice.Formalin-inactivated EV71 vaccine candidate induced cross-neutralizing antibody against subgenotypes B1, B4, B5 and C4A in adult volunteers.Recombinant adeno-vaccine expressing enterovirus 71-like particles against hand, foot, and mouth diseaseImmunological evaluation and comparison of different EV71 vaccine candidates.Caveolar endocytosis is required for human PSGL-1-mediated enterovirus 71 infectionReview of enterovirus 71 vaccines.Monoclonal antibodies for diagnosis of enterovirus 71.Development of a full-length cDNA-derived enterovirus A71 vaccine candidate using reverse genetics technology.Immunogenicity of an adeno-vector vaccine expressing the F protein of a respiratory syncytial virus manufactured from serum-free suspension culture.Immunological and biochemical characterizations of coxsackievirus A6 and A10 viral particles.A Phase I, randomized, open-label study to evaluate the safety and immunogenicity of an enterovirus 71 vaccine.Optimization of microcarrier cell culture process for the inactivated enterovirus type 71 vaccine development.High immunogenic enterovirus 71 strain and its production using serum-free microcarrier Vero cell culture.Recent development of enterovirus A vaccine candidates for the prevention of hand, foot, and mouth diseaseSelection and characterization of vaccine strain for Enterovirus 71 vaccine developmentGeneration of murine monoclonal antibodies which cross-neutralize human enterovirus genogroup B isolatesDevelopment of a quantitative enzyme linked immunosorbent assay for monitoring the Enterovirus 71 vaccine manufacturing process
P50
Q24337770-25B7575A-F97F-435A-AC35-D3D6A02BEADDQ27485473-B15CB995-9419-42FF-88A7-8807D406CDD5Q28478931-C343F2D2-B8EE-4B89-A60E-5086A605B9D2Q28485432-72173B8E-53D5-47F1-BCF9-6B05BB451D03Q28660283-97BE8CAD-F4EE-4BF4-92E3-782D58495184Q31056961-71BE2D30-3B09-4776-A8BD-4FF89BECAE87Q33809953-D526A0E8-66B9-4E67-8245-0BAE7A2A4027Q33908518-9AE54750-5F30-40D4-B757-CFFC761940CFQ34149853-AAADA804-11CE-4611-9B58-6CF5472FAAFAQ34177586-9043364D-98A1-4736-AAA4-177E08F8BBD2Q34603659-6686B814-0B53-4D6E-AB88-237C30B04ADFQ34921442-BE9E8390-46B5-4BDF-87BA-E959B7684FB9Q35053266-C818C885-FE21-446E-BE33-B779B4592CD7Q35345853-7C84F91E-96C7-49A0-8127-0F7BE3581F51Q36248450-0BD6FC2A-3BC6-4712-99C6-ACDAF9426529Q37123229-23289AF4-ECDA-4E9F-99B6-EB80E7E1B2D1Q38263484-85DE5522-740C-4339-A55A-AC432FF5E4B9Q39044450-8E44EB85-7708-48A5-B813-CBC74AD7C00AQ40622180-4E04EBE9-7C67-45F1-9E1B-248F4A7C79EAQ40746340-A460310E-C7A3-49F7-9BE9-9BADBA1ACA17Q40783162-140D6610-DC55-433D-A606-B14C9CC8A733Q42694361-3F059D21-541B-4CBD-8FB1-0DDD9C9CADDCQ45056729-66CC7399-4CAD-46D5-B9A2-A263157DD151Q51143326-104A7971-1CA1-4F36-80DB-4165BEA4346BQ59354804-BCC49D21-090E-4992-9E2E-B26A9BA77232Q82811412-16E3E43B-C022-44CA-B233-F6CED2E78466Q83399285-6F24D9DE-82FA-4431-A159-B1D3E281E3EBQ84443635-D680B195-936E-4D54-BD3A-D6DF071368D7
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Chia-Chyi Liu
@ast
Chia-Chyi Liu
@en
Chia-Chyi Liu
@es
Chia-Chyi Liu
@sl
type
label
Chia-Chyi Liu
@ast
Chia-Chyi Liu
@en
Chia-Chyi Liu
@es
Chia-Chyi Liu
@sl
prefLabel
Chia-Chyi Liu
@ast
Chia-Chyi Liu
@en
Chia-Chyi Liu
@es
Chia-Chyi Liu
@sl
P1053
A-8215-2012
P106
P31
P3829
P496
0000-0002-6257-0389